Since the normal, non-implanted rat ovary was not affected by DMBA treatment the malignant transformation of splenic ovaries in the respective experimental groups may be related to the increased stimulation by pituitary gonadotrophins and formation of luteomata or beginning granulosa and theca cell proliferations.
OVARIAN tissue was found to develop benign granulosa or granulosa-theca cell tumours after implantation into the spleen of gonadectomized rats (Biskind and Biskind, 1944) as the result of an adaptive hyperplasia (Bungeler and Dontenwill, 1959) . This mechanism has been explained by uninhibited pituitary stimulation (Heller and Jungck, 1947; Miller and Pfeiffer, 1950;  Achilles and Sturgis, 1951; Kullander, 1956) ; because steroids secreted from the implant pass directly through the portal system to the liver where they are inactivated (Golden and Sevringhaus, 1938;  Leavitt, Carlson and Meyer, 1971) , and the feedback mechanism is interrupted between pituitary and ovarian tissue.
Since chemnicals may lead to malignant transformation, the effects of a polycyclic hydrocarbon and a nitroso-compound were examined in this model of induction of benign ovarian tumours (splenic ovaries). * Supported by Deutsche Forschungsgemeinschaft.
MATERIALS AND METHODS
One hundred and ten female, 3-month old Sprague-Dawley rats from our colony were ovariectomized under ether (Pronarcosi, Hoechst) anaesthesia, and a piece of ovary 2 mm in diameter was implanted into the spleen according to the method described by Biskind and Biskind (1949 the animals died from rupture of these tumours and bleeding into the abdominal cavity. Histologically, in both groups these areas showed malignant granulosa cell proliferation with polymorphism and hyperchromasia of the nuclei as well as numerous mitoses. In addition to solid tumour parts, typical fluid-or bloodfilled cystic changes occurred similar to the " folliculoma malignum " (Novak and Woodruff, 1968) , which resembled the structures of Graafian follicles. Cells of these " follicles " invaded the surrounding tissue (Fig. 4) or filled the lumen of the cysts by papillary growth (Fig. 5) , and central necroses very often occurred. In 3 cases metastases were found in liver and lungs ( Fig. 6 and 7) . One tumour, 41 weeks after beginning of DMBA treatment and 66 weeks after implantation, showed a striking solid consistency (Fig. 8) and was diagnosed as a malignant thecoma with only a few granulosa cell areas. Spindlelike and sometimes epithelioid cells formed an irregular, whorl-like pattern (Fig. 9) , and frequent mitoses and typical formation of fibres were seen. Areas of calcification could be found. Malignant cells invaded the vascularised connective tissue. Luteinization of the malignant granulosa cell tumours and the thecoma was diffuse and minimal in comparison with the controls. When DMBA was administered immediately after implantation of ovarian tissue, the first malignant transformation in the splenic ovary was seen after 22 weeks, and 16 weeks after treatment when administration began 25 weeks later. In general, the rats of both DMBA treated groups did not die from malignant splenic ovaries but from leukaemias, often bilateral tumours (adenomata and mostly carcinomata) of the periauricular sebaceous gland (Zymbal, 1933) ; occasionally multiple skin (sebaceous adenomata, sebaceous basal and squamous cell carcinomata) or mammary tumours (adenocarcinomata, fibrosarcomata and in one case a carcinosarcoma). The results for these groups can be seen in Table I. 3. DEN treatment The splenic ovaries of rats treated immediately or 25 weeks after implantation showed macroscopically and histologically no differences from the controls. Most of these animals died from extensive hepatomata and partly metastasizing hepatocellular carcinomata. Table I shows the results of the DEN experimental groups.
DISCUSSION
These experiments show that treatment of splenic ovaries with DMBA led to the transformation of the ovarian tissue into malignant, partially metastasizing tumours, as has been briefly reported previously Mohr, 1971, 1972) . Since the neoplasms were granulosa and theca cell tumours, ovarian cells were the tissue of origin.
The histogenesis of tumour development after implantation of ovarian tissue into the spleen of ovariectomized rats has been described by several authors (Biskind and Biskind, 1944; 1949; Deane and Fawcett, 1956; Kullander, 1956; Ranz, 1960; Myhre, 1962) . The neoplastic alterations in the ovarian implant develop because follicles remain unruptured and after destruction of the oocytes, corpora lutea are formed resulting in the development of luteomata. Areas with granulosa cells showing increased mitotic activity are seen 4-8 months after implantation. The tumours are not uniform in their composition; luteal tissue, areas of granulosa cells and parts of theca cells embedded in fibrous connective tissue are present in different patterns. Metastases of these tumours were not observed (Biskind and Biskind, 1949; Bungeler and Dontenwill, 1959; Ranz, 1960) .
Granulosa or granulosa-theca cell tumours after implantation of ovarian tissue into the spleen were also reported in mice, rabbits and guinea-pigs (Lipschutz, 1946; Furth and Sobel, 1947; Li and Gardner, 1947; Peckham, Breene and Jeffries, 1948; Miller and Pfeiffer, 1950; FIG. 5 Fig. 11 ). II. and E. x 580. Klein, 1952; Li and Gardner, 1952; Iglesias, Mardones and Lipschutz, 1953; Gardner, 1955; Mardones, Iglesias and Lipschutz, 1955; Guthrie, 1957) . In rats the application of DMBA led to the malignant transformation of the ovarian tissue and to the development of malignant granulosa, and in one case theca cell tumours.
The malignant neoplastic changes observed in 6 animals (30 %o) treated with DMBA immediately following implantation of ovarian tissue into the spleen were mostly found to be multi-focal inside the benign luteal changes or in granulosa-theca cell proliferations. In comparison with these observations, in the second DMBA treated group (application 25 weeks after implantation), more extensive malignant tumours were found in a higher percentage of animals (65%) and parts of the " normal " benign splenic ovary were rarely observed. It may therefore be assumed that the carcinogen only affects the stage of luteinization or the proliferation of granulosa and theca cells. Possibly, the similarity between the chemical structure of the polycyclic hydrocarbon and steroid hormones (Yang et al., 1961) and the similarity of their biological effects (Jull, 1956) interfere with the metabolism of luteinized cells. Since no malignant alterations were found after DEN treatment, the mechanism described before might be supported. In contrast to the results in mice (Howell, Marchant and Orr, 1954; Marchant, 1957; Mody, 1960; Biancifiori, Bonser and Caschera, 1961; Krarup, 1967 Krarup, , 1970 Kuwahara, 1967; Krarup and Loft, 1971) and hamsters (Toth, 1971) where DMBA treatment led to the development of granulosa or granulosa-theca cell tumours, rat orthotopic ovaries are not affected by DMBA (Marchant, 1957; Kuwahara, 1967 
